Please assess the completion status of the following clinical trial:

Trial Title: Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 or older~* Written informed consent~Exclusion Criteria:~* Pregnant women~* Creatinine clearance less than 60 ml/min~* BMI greater than 40~* Currently use greater than 80mg morphine-equivalents daily (pre-operatively)~* Receive a unicondylar knee replacement

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- ROP/KET/CLON/EPI/SAL (Type: EXPERIMENTAL): Ropivacaine (ROP) (5mg/ml)- 50ml Ketorolac (KET) (30mg/ml)- 1ml Clonidine (CLON) (0.1mg/ml)- 0.8ml Epinephrine (EPI) (1mg/ml)- 0.5ml 0.9% sodium chloride SAL)--47.7 ml
- Placebo (Type: PLACEBO_COMPARATOR): 0.9% Sodium Chloride- 100ml

Based on this trial design, predict the completion outcome and termination type (if applicable).